Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis.

Thromb J · 2023 · PMC10347711 · PMID 37452333

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although not statistically significant, the proportion of patients achieving TMPG 3 and cTFC also showed a favorable trend in the IC group compared with that in the IV group (Fig. 1 ).

also in 887 other papers

borderline significanceno p-value reported

The difference in the LVEF after 6 months or longer was also higher in the IC group, with borderline significance (SMD: 0.25, 95% CI: 0.03–0.48).

also in 2,877 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.